The PPARα–leukotriene B4 pathway to inflammation control
The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Abstract
Inflammation is a local immune response to 'foreign' molecules, infection and injury. Leukotriene B4, a potent chemotactic agent that initiates, coordinates, sustains and amplifies the inflammatory response, is shown to be an activating ligand for the transcription factor PPARalpha. Because PPARalpha regulates the oxidative degradation of fatty acids and their derivatives, like this lipid mediator, a feedback mechanism is proposed that controls the duration of an inflammatory response and the clearance of leukotriene B4 in the liver. Thus PPARalpha offers a new route to the development of anti- or pro-inflammatory reagents.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“FFAs act as PPAR agonists facilitating translocation to the nucleus and dimerization to RXR [77,78].”
From Lipoprotein Lipase Regulates Microglial Lipid Droplet Accumulation (2021) · cites this paper as [77]
In the citing paper
“PPAR-α is involved in the regulation of pro-inflammatory genes, mainly by limiting cytokine expression.[109]”
From Nuclear receptors in liver fibrosis (2021) · cites this paper as [109]
Citations
Cites
Lehmann, J. M., Moore, L. B., Smith-Oliver, T. A., Wilkison, W. O., Willson, T. M., & Kliewer, S. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.22.12953 · Cited by 3,625
Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators
Issemann, I., & Green, S. (1990) · Nature · doi:10.1038/347645a0 · Cited by 3,519
15-Deoxy-Δ12,14-Prostaglandin J2 is a ligand for the adipocyte determination factor PPARγ
Forman, B. M., Tontonoz, P., Chen, J., Brun, R. P., Spiegelman, B. M., & Evans, R. M. (1995) · Cell · doi:10.1016/0092-8674(95)90193-0 · Cited by 2,858
Leukotrienes and Lipoxins: Structures, Biosynthesis, and Biological Effects
Samuelsson, B., Dahlén, S.-E., Lindgren, J. Å., Rouzer, C. A., & Serhan, C. N. (1987) · Science · doi:10.1126/science.2820055 · Cited by 2,233
Braissant, O., Foufelle, F., Scotto, C., Dauça, M., & Wahli, W. (1996) · Endocrinology · doi:10.1210/endo.137.1.8536636 · Cited by 2,217
Self-citationKliewer, S. A., Lenhard, J. M., Willson, T. M., Patel, I., Morris, D. C., & Lehmann, J. M. (1995) · Cell · doi:10.1016/0092-8674(95)90194-9 · Cited by 2,028
Kliewer, S. A., Umesono, K., Noonan, D. J., Heyman, R. A., & Evans, R. M. (1992) · Nature · doi:10.1038/358771a0 · Cited by 1,741
Lee, S. S.-T., Pineau, T., Drago, J., Lee, E. J., Owens, J. W., Kroetz, D. L., Fernandez-Salguero, P. M., Westphal, H., & Gonzalez, F. J. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.6.3012 · Cited by 1,655
Self-citationKliewer, S. A., Forman, B. M., Blumberg, B., Ong, E. S., Borgmeyer, U., Mangelsdorf, D. J., Umesono, K., & Evans, R. M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.15.7355 · Cited by 1,400
Control of the peroxisomal β-oxidation pathway by a novel family of nuclear hormone receptors
Dreyer, C., Krey, G., Keller, H., Givel, F., Helftenbein, G., & Wahli, W. (1992) · Cell · doi:10.1016/0092-8674(92)90031-7 · Cited by 1,376
Self-citationKeller, H., Dreyer, C., Medin, J., Mahfoudi, A., Ozato, K., & Wahli, W. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.6.2160 · Cited by 948
Self-citationThe eicosanoids and their biochemical mechanisms of action
Smith, W. L. (1989) · Biochemical Journal · doi:10.1042/bj2590315 · Cited by 871
Lemberger, T., Desvergne, B., & Wahli, W. (1996) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.12.1.335 · Cited by 712
Self-citationDifferential Activation of Peroxisome Proliferator-activated Receptors by Eicosanoids
Yu, K., Bayona, W., Kallen, C. B., Harding, H. P., Ravera, C. P., McMahon, G., Brown, M., & Lazar, M. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.41.23975 · Cited by 711
Sher, T., Yi, H. F., McBride, O. W., & Gonzalez, F. J. (1993) · Biochemistry · doi:10.1021/bi00072a015 · Cited by 519
Self-citationSchmidt, A. (1992) · Molecular Endocrinology · doi:10.1210/me.6.10.1634 · Cited by 477
Role of leukotrienes revealed by targeted disruption of the 5-lipoxygenase gene
Chen, X.-S., Shelter, J. R., Johnson, E. N., & Funk, C. D. (1994) · Nature · doi:10.1038/372179a0 · Cited by 414
Greene, M. E., Blumberg, B., McBride, O. W., Yi, H., Kronquist, K. E., Kwan, K. W., Hsieh, L., Greene, G. L., & Nimer, S. D. (1995) · Europe PMC (PubMed Central) · Cited by 399
Gad, S. C., Dunn, B. J., Dobbs, D. W., Reilly, C., & Walsh, R. D. (1986) · Toxicology and Applied Pharmacology · doi:10.1016/0041-008x(86)90419-9 · Cited by 384
Zhu, Y., Alvares, K., Huang, Q., Rao, M. S., & Reddy, J. K. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)74184-2 · Cited by 374
Cloning of a Protein That Mediates Transcriptional Effects of Fatty Acids in Preadipocytes
Amri, E.-Z., Bonino, F., Ailhaud, G., Abumrad, N. A., & Grimaldi, P. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.5.2367 · Cited by 368
Lemberger, T., Saladin, R., Vázquez, M., Assimacopoulos, F., Staels, B., Desvergne, B., Wahli, W., & Auwerx, J. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.3.1764 · Cited by 329
Self-citationCarlson, R. P., Lynn, O.-D., Chang, J., & Lewis, A. J. (1985) · Agents and Actions · doi:10.1007/bf01966592 · Cited by 307
Leukotriene B4 in inflammation.
Ford‐Hutchinson, A. W. (1990) · PubMed · Cited by 297
Serhan, C. N., Fridovich, J., Goetzl, E. J., Dunham, P. B., & Weissmann, G. (1982) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)34588-5 · Cited by 238
Chen, F., Law, S. W. T., & O’Malley, B. W. (1993) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1993.2302 · Cited by 156
Peters, J., Zhou, Y., Ram, P. A., Lee, S. S., Gonzalez, F. J., & Waxman, D. J. (1996) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09162-x · Cited by 144
Self-citationKikuta, Y., Kusunose, E., Endo, K., Yamamoto, S., Sogawa, K., Fujii-Kuriyama, Y., & Kusunose, M. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)98360-2 · Cited by 135
Göttlicher, M., Demoz, A., Svensson, D., Tollet, P., Berge, R. K., & Gustafsson, J.-Α. (1993) · Biochemical Pharmacology · doi:10.1016/0006-2952(93)90607-x · Cited by 123
Hussain, H. B., Shornick, L. P., Shannon, V. R., Wilson, J. D., Funk, C. D., Pentland, A. P., & Holtzman, M. J. (1994) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1994.266.1.c243 · Cited by 123
Prostaglandin and Leukotriene Synthesis in Mouse Ears Inflamed by Arachidonic Acid
Opas, E. E., Bonney, R. J., & Humes, J. L. (1985) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12265320 · Cited by 120
Peroxisomal degradation of leukotrienes by beta-oxidation from the omega-end.
Jedlitschky, G., Huber, M., Völkl, A., Müller, M. M., Leier, I., Müller, J., Lehmann, W. D., Fahimi, H. D., & KEPPLER, D. O. R. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)54295-2 · Cited by 115
Hertz, R., Berman, I., KEPPLER, D. O. R., & Bar‐Tana, J. (1996) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1996.00242.x · Cited by 104
Krey, G. D., Keller, H., Mahfoudi, A., Medin, J. A., Ozato, K., Dreyer, C., & Wahli, W. (1993) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(93)90058-5 · Cited by 104
Self-citationHarper, T. W., Garrity, M. J., & Murphy, R. C. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)57231-3 · Cited by 82
Aperlo, C., Pognonec, P., Saladin, R., Auwerx, J. H., & Boulukos, K. E. (1995) · Gene · doi:10.1016/0378-1119(95)00196-d · Cited by 80
Dietary n − 3 fatty acids accelerate catabolism of leukotriene B4 in human granulocytes
von Schacky, C., Kiefl, R., Marcus, A. J., Broekman, M. J., & Kaminski, W. E. (1993) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(93)90278-h · Cited by 39
Peroxisomal leukotriene degradation: Biochemical and clinical implications
Jedlitschky, G., Mayatepek, E., & KEPPLER, D. O. R. (1993) · Advances in Enzyme Regulation · doi:10.1016/0065-2571(93)90017-8 · Cited by 31
Cell-Cell Interactions in the Release of Inflammatory Mediators
Wong, P. Y.-K., & Serhan, C. N. (1991) · Advances in experimental medicine and biology · doi:10.1007/978-1-4684-6024-7 · Cited by 29
Miller, A. M., van Bekkum, D. W., Kobb, S. M., McCROHAN, M., & Knaän‐Shanzer, S. (1993) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/0952-3278(93)90161-o · Cited by 16
LTB4 and PAF in the Cytokine Network
Rola‐Pleszczynski, M. (1991) · Advances in experimental medicine and biology · doi:10.1007/978-1-4684-6024-7_13 · Cited by 13
Couve, A., Koenig, C. S., & Santos, M. J. (1992) · Experimental Cell Research · doi:10.1016/0014-4827(92)90109-l · Cited by 13
Disappearance and metabolism of leukotriene B4 during carrageenan-induced pleurisy
Taylor, B. M., & Sun, F. F. (1985) · Biochemical Pharmacology · doi:10.1016/0006-2952(85)90723-3 · Cited by 8
Research works printed but not linked: 6
- Ford-Hutchinson, A. W. Crit. Rev. Immunol. 10, 1–11 (1990).
- Desvergne, B. & Wahli, W. in Inducible Transcription Vol. 1 (ed. Bæuerle, P.) 142–176 (Birkhäuser, Boston, 1995).
- Greene, M. E. et al. Gene Expr. 4, 281–299 (1995).
- Schmidt, A. et al. Mol. Endocrinol. 6, 1634–1641 (1992).
- Yu, K. et al. J. Biol. Chem. 270, 23975–23983 (1995). · DOI · Paper page
- Peters, J. M. et al. Mol. Pharmacol. 50, 67–94 (1996).
Cited by
Prostaglandins and Leukotrienes: Advances in Eicosanoid Biology
Funk, C. D. (2001) · Science · doi:10.1126/science.294.5548.1871 · Cited by 3,817
Peroxisome Proliferator-Activated Receptors: Nuclear Control of Metabolism*
Desvergne, B., & Wahli, W. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.5.0380 · Cited by 3,086
Self-citationPPAR-γ agonists inhibit production of monocyte inflammatory cytokines
Jiang, C., Ting, A. T., & Seed, B. (1998) · Nature · doi:10.1038/34184 · Cited by 2,899
(1998) · PubMed · Cited by 2,737
The mechanisms of action of PPARs
Berger, J., & Moller, D. E. (2002) · Annual Review of Medicine · doi:10.1146/annurev.med.53.082901.104018 · Cited by 2,659
“PPARα was first proposed to be a modulator of inflammation when leukotriene B4 (LTB4), a potent chemotactic agent, was found to be a ligand and agonist for the receptor (160).”
Background
Metadata
- Authors
- Devchand, P. R., Keller, H., Peters, J. M., Vazquez, M., Gonzalez, F. J., & Wahli, W.
- Affiliations
- University of Lausanne (CH)
- National Institutes of Health (US)
- Venue
- Nature
- Published
- 1996-11
- Volume
- 384
- Issue
- 6604
- Pages
- 39-43
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1671834350
- Cited by
- 1,345
- References
- 43
- Citations by year
- 2026: 3 · 2025: 17 · 2024: 14 · 2023: 21 · 2022: 9 · 2021: 38 · 2020: 30 · 2019: 23 · 2018: 21 · 2017: 24 · 2016: 23 · 2015: 22 · 2014: 43 · 2013: 34 · 2012: 49
- FWCI
- 28.15
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- IRIS (submittedVersion)
- SERVAL (Université de Lausanne) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
- Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
- Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
- Keywords
- PPARα, leukotriene B4, inflammation, transcription factor activation, fatty acid oxidation, lipid mediators, chemotaxis, anti-inflammatory agents, liver, feedback regulation
- MeSH terms
- Adaptation, Physiological, Animals, Cells, Cultured, Fatty Acids, Female, Gene Expression Regulation, HeLa Cells, Humans, Inflammation, Leukotriene B4, Ligands, Liver, Male, Oxidation-Reduction, Plasmids, Pyrimidines, Time Factors, Transcription Factors, Transfection, Chloramphenicol O-Acetyltransferase, Arachidonic Acid, Rats, Sprague-Dawley, Receptors, Cytoplasmic and Nuclear, Inflammation Mediators, Mice, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.